ArticleJournal of leukocyte biology2026

HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer.

Olga-Demetra Biziotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.